Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_assertion description "[The small molecule ET(A)R antagonist achieves concomitant suppression of tumor growth and EMT effectors, providing a new opportunity for therapeutic intervention in which targeting ILK pathway and the related Snail and beta-catenin signaling cascade via ET(A)R blockade may be advantageous in the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_assertion evidence source_evidence_literature NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_assertion SIO_000772 17587812 NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_assertion wasDerivedFrom befree-2016 NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_assertion wasGeneratedBy ECO_0000203 NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.
- befree-2016 importedOn "2016-02-19" NP616578.RAiSUz0jQCCobQaiPAhz_IGbO4Hz7jEoNwlm8FVBU234I130_provenance.